These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3043916)

  • 1. [Results of cyclosporin A therapy in the early phase of type I diabetes mellitus].
    Schernthaner G; Aschauer-Treiber G; Gaube S; Klösch-Kasparek D; Müller C; Zielinski C
    Wien Klin Wochenschr; 1988 Jun; 100(13):454-9. PubMed ID: 3043916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunosuppression with cyclosporin induces clinical remission and improved beta cell function in patients with newly diagnosed insulin-dependent diabetes. A national and international multicenter study].
    Mandrup-Poulsen TR; Mølvig JC; Andersen V; Bendtzen K; Binder C; Brøns M; d'Amore FA; Dieperink H; Enk B; Frandsen NE
    Ugeskr Laeger; 1990 Jul; 152(27):1963-9. PubMed ID: 2195734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal side effects of high and low cyclosporin A doses in patients with rheumatoid arthritis.
    Berg KJ; Førre O; Djøseland O; Mikkelsen M; Narverud J; Rugstad HE
    Clin Nephrol; 1989 May; 31(5):232-8. PubMed ID: 2661065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical trials of cyclosporin in IDDM.
    Dupré J; Stiller CR; Gent M; Donner A; von Graffenried B; Heinrichs D; Jenner M; Keown P; Mahon J; Martell R
    Diabetes Care; 1988; 11 Suppl 1():37-44. PubMed ID: 3069390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Induction of remissions of insulin-dependent diabetes by cyclosporin].
    Feutren G; Papoz L; Assan R; Vialettes B; Pehuet M; Vexiau P; Durostu H; Rodier M; Sirmai J; Lallemand A
    C R Acad Sci III; 1986; 303(8):295-7. PubMed ID: 3094846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppression in autoimmune disease: the double-edged sword.
    Jaworski MA; Jewell LD; Honore L; Mehta JG; Bayens-Simmonds J; McGuire-Clark P; Schouls JJ; Yap WY
    Clin Invest Med; 1987 Sep; 10(5):488-95. PubMed ID: 3315371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal renal function 8 to 13 years after cyclosporin A therapy in 285 diabetic patients.
    Assan R; Blanchet F; Feutren G; Timsit J; Larger E; Boitard C; Amiel C; Bach JF
    Diabetes Metab Res Rev; 2002; 18(6):464-72. PubMed ID: 12469360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cyclosporin in autoimmune diseases].
    Frey FJ
    Schweiz Med Wochenschr; 1990 May; 120(21):772-86. PubMed ID: 2190313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum angiotensin-converting enzyme levels in patients with recent-onset insulin-dependent diabetes after one year of low-dose cyclosporin therapy. IMDIAB Study Group.
    Letizia C; d'Ambrosio C; De Ciocchis A; Scavo D; Pozzilli P
    Int J Clin Pharmacol Res; 1995; 15(5-6):209-13. PubMed ID: 8835619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporine trials in diabetes: updated results of the French experience.
    Assan R; Feutren G; Sirmai J
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):178-83. PubMed ID: 3289203
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of the therapeutic range of whole blood cyclosporin concentration in the treatment of psoriasis.
    Ieiri I; Nakayama J; Murakami H; Hori Y; Higuchi S
    Int J Clin Pharmacol Ther; 1996 Mar; 34(3):106-11. PubMed ID: 8705088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Will type I diabetes mellitus be treated with immunosuppressive drugs in the future?].
    Diem P
    Ther Umsch; 1993 Feb; 50(2):114-8. PubMed ID: 8456415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Latent autoimmune diabetes in adults(LADA): part of the clinical spectrum of type-1 diabetes mellitus of autoimmune origin].
    Pánczél P; Hosszúfalusi N; Bornemisza B; Horváth L; Jánoskuti L; Füst G; Rajczy K; Vatay A; Prohászka Z; Madácsy L; Luczay A; Blatniczky L; Halmos T; Körner A; Szilvási I; Romics L
    Orv Hetil; 2001 Nov; 142(46):2571-8. PubMed ID: 11770176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial.
    De Jager J; Kooy A; Lehert P; Bets D; Wulffelé MG; Teerlink T; Scheffer PG; Schalkwijk CG; Donker AJ; Stehouwer CD
    J Intern Med; 2005 Jan; 257(1):100-9. PubMed ID: 15606381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of cyclosporin A on the induction of experimental autoimmune thyroid disease in the PVG/c rat.
    Hassman RA; Dieguez C; Rennie DP; Weetman AP; Hall R; McGregor AM
    Clin Exp Immunol; 1985 Jan; 59(1):10-6. PubMed ID: 3971595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset. Results of a multicentre double-blind trial.
    Feutren G; Papoz L; Assan R; Vialettes B; Karsenty G; Vexiau P; Du Rostu H; Rodier M; Sirmai J; Lallemand A
    Lancet; 1986 Jul; 2(8499):119-24. PubMed ID: 2873396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New findings on the pathogenesis of diabetes mellitus].
    Keller U
    Schweiz Med Wochenschr; 1986 Jan; 116(3):66-71. PubMed ID: 3511524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The kidney in cyclosporin A-treated diabetic patients: a long-term clinicopathological study.
    Assan R; Timsit J; Feutren G; Bougnères P; Czernichow P; Hannedouche T; Boitard C; Noel LH; Mihatsch MJ; Bach JF
    Clin Nephrol; 1994 Jan; 41(1):41-9. PubMed ID: 8137568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-1 beta induced transient diabetes mellitus in rats. A model of the initial events in the pathogenesis of insulin-dependent diabetes mellitus?
    Reimers JI
    Dan Med Bull; 1998 Apr; 45(2):157-80. PubMed ID: 9587701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The combination of cyclosporin A and fluocortolone in the treatment of autoimmune diseases].
    Aresu G; Pascalis L; Pia G
    Clin Ter; 1989 Oct; 131(1):3-21. PubMed ID: 2531058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.